Stockman Wealth Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Stockman Wealth Management’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-4,233	Closed	-$277K	–	157
2017 Q3	$277K	Buy	4,233 +4	+0.1%	+$253	0.13%	117
2017 Q2	$265K	Sell	4,229 -2,849	-40%	-$171K	0.26%	95
2017 Q1	$416K	Sell	7,078 -2,996	-30%	-$175K	0.24%	86
2016 Q4	$564K	Buy	10,074 +151	+2%	+$8.7K	0.34%	63
2016 Q3	$612K	Buy	+9,923	New	+$650K	0.38%	61

Other funds holding PJP

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Stockman Wealth Management's PJP Position: Q4 2017 in Review

Stockman Wealth Management sold out of Invesco Pharmaceuticals ETF (PJP) in Q4 2017, closing a stake of 4,233 shares — an estimated $277K sold.

Stockman Wealth Management first reported a position in PJP in Q3 2016 and held it in 5 quarters. The position peaked at $612K in Q3 2016. 92 funds tracked by Wall St. Rank hold PJP as of Q4 2017.

Stockman Wealth Management reported no remaining Invesco Pharmaceuticals ETF position as of Q4 2017 after selling out during the quarter.
Stockman Wealth Management sold 4,233 Invesco Pharmaceuticals ETF shares in Q4 2017, an estimated $277K.
Stockman Wealth Management first reported a position in Invesco Pharmaceuticals ETF in Q3 2016 and held it in 5 quarters.
Stockman Wealth Management's Invesco Pharmaceuticals ETF position peaked at $612K in Q3 2016.
92 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q4 2017.

Based on Stockman Wealth Management's 13F filing for Q4 2017, filed 12 Feb 2018.